Macrophage migration inhibitory factor (MIF) inhibitor 4‐IPP suppresses osteoclast formation and promotes osteoblast differentiation through the inhibition of the NF‐κB signaling pathwayLin Zheng, Dengwei He, Jiawei Gao et al.|The FASEB Journal|2019Cited by 49
TGF‑β inhibitor RepSox suppresses osteosarcoma via the JNK/Smad3 signaling pathwayDengwei He, Shunwu Fan|International Journal of Oncology|2021Cited by 32
Azilsartan Suppresses Osteoclastogenesis and Ameliorates Ovariectomy-Induced Osteoporosis by Inhibiting Reactive Oxygen Species Production and Activating Nrf2 SignalingBin Pan, Dengwei He, Lin Zheng et al.|Frontiers in Pharmacology|2021Cited by 21
MiR-148a deletion protects from bone loss in physiological and estrogen-deficient mice by targeting NRP1Bin Pan, Dengwei He, Lin Zheng et al.|Cell Death Discovery|2022Cited by 20
Chicago sky blue 6B (CSB6B), an allosteric inhibitor of macrophage migration inhibitory factor (MIF), suppresses osteoclastogenesis and promotes osteogenesis through the inhibition of the NF-κB signaling pathwayKangtao Jin, Dengwei He, Lin Zheng et al.|Biochemical Pharmacology|2021Cited by 17